honeybee
Researchers
Ragweed Allergy (Seasonal Allergic Rhinitis)
Cliantha Research, Clinical Research Organization (CRO)
The purpose of this study is to assess the onset of action and effectiveness of DYMISTA® nasal spray in relieving your nasal and ocular allergy symptoms caused by ragweed pollen in an Environmental Exposure Unit/Chamber (EEC).
Eligibility Criteria
Female, Male
18 to 55 years old
At least a 2-year medical history of allergy to ragweed
Not have current diagnosis of asthma
Not have received ragweed immunotherapy within the last 6 months
Other inclusion/exclusion criteria will be assessed
Study Tasks
Informed Consent Document (ICF)
Medical history and demographic data
Measurement of vital signs and physical examination
Skin prick test (SPT) to show positivity to ragweed allergen
Spirometry to test lung function
Exposure to ragweed pollen in an Environmental Exposure Chamber (EEC)
COVID-19 screening/testing
Ethics
This study has been approved by Advarra Ethics Board
Keywords
Activity and Time
Investigational Medicine
Clinical Trial
Weekdays, Weekends
56 days total, 5 sessions
After the initial phone screening, in-clinic general screening will be conducted to confirm allergy to ragweed (compensation of $50 upon completion of visit procedures) and other procedures. Participants who screen pass general screening will be eligible to continue to the medical screening visit.
Compensation
Up to $2325
Study Address
4500 Dixie Rd Mississauga, Ontario, Canada, L4W 1N2
Earn $2325